• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT IRELAND ARCHITECT TOTAL PSA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT IRELAND ARCHITECT TOTAL PSA Back to Search Results
Catalog Number 07K70-27
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/12/2018
Event Type  malfunction  
Manufacturer Narrative
This report is being filed on an international product, architect total psa, list 7k70, that has a similar product distributed in the us, total psa, list number 6c06.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Patient information: no specific patient information was provided.
 
Event Description
The customer reported falsely elevated architect total psa results for a patient undergoing treatment for prostate cancer.The customer provided the following results and indicated the results generated in may and september were falsely elevated.On (b)(6) 2018: 0.193.On (b)(6) 2018: 5.505.On (b)(6) 2018: 26.800.On (b)(6) 2018: 13.058.On (b)(6) 2018: 5.663.No adverse impact to patient management was reported.
 
Manufacturer Narrative
Review of complaint activity did not identify any adverse or non-statistical trends for the architect total psa assay.Using worldwide field data the historical performance of the assay was reviewed.The patient median result for each reagent lot was analyzed and found to be within 2 standard deviations of the established baseline, confirming no systemic issue for the assay.Manufacturing documentation for the assay did not identify any issues associated with the complaint issue.Additionally, labeling was reviewed and sufficiently addresses the customer's issue.Based on the available information, no systemic issue or deficiency of the architect total psa assay was identified.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT TOTAL PSA
Type of Device
TOTAL PSA
Manufacturer (Section D)
ABBOTT IRELAND
diagnostics division
finisklin business park
sligo NA
EI  NA
MDR Report Key8430355
MDR Text Key142634690
Report Number3008344661-2019-00031
Device Sequence Number1
Product Code MTF
Combination Product (y/n)N
PMA/PMN Number
P910007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 04/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number07K70-27
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 02/25/2019
Initial Date FDA Received03/18/2019
Supplement Dates Manufacturer Received04/05/2019
Supplement Dates FDA Received04/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ARCHITECT I2000SR, LIST 03M74-01; ARCHITECT I2000SR, LIST 03M74-01; SERIAL ISR60586; SERIAL ISR60586
-
-